Bolt Biotherapeutics, Inc. BOLT 深 滬
等待開盤 03-26 09:30:00 美东时间
4.50
+0.210
+4.90%
華盛通- 最 高4.55
- 今 開4.465
- 成交量 1.26万股
- 最 低 4.26
- 昨 收 4.29
- 總市值 863.75万
- 52周最高 9.248
- 市盈率 靜 --
- 換手率 0.65%
- 52周最低 3.91
- 委 比 63.93%
- 總股本 191.94万
- 歷史最高 861.40
- 量 比 0.64
- 振 幅 6.76%
- 歷史最低 3.91
- 每 手 1
- 風險率 0.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
HC Wainwright & Co. Reiterates Buy on Bolt Biotherapeutics, Maintains $7 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Bolt Biotherapeutics (NASDAQ:BOLT) with a Buy and maintains $7 price target.
03-13 18:12
Bolt Biotherapeutics Q4 EPS $(3.84) Beats $(4.30) Estimate, Sales $2.500M Beat $666.667K Estimate
Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(3.84) per share which beat the analyst consensus estimate of $(4.30) by 10.7 percent. This is a 49.47 percent increase over losses of $(7.60) per share
03-13 04:14
Bolt Biotherapeutics to Participate in Upcoming March Conferences
Bolt Biotherapeutics, a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for cancer, announced its participation in two upcoming conferences in March 2026. On March 2, the company will present at the TD Cowen 46th Annual Health Care Conference, and on March 11, management will engage in 1x1 meetings at the Leerink Partners Global Healthcare Conference. Bolt Biotherapeutics is advancing BDC-4182, a next-generati...
02-24 13:00
ADVISORY-Alert wrongly tagged to Bolt Biotherapeutics Inc withdrawn
ADVISORY-Alert wrongly tagged to Bolt Biotherapeutics Inc withdrawn An alert on privately-held company Bolt providing checkout, identity and payments services was wrongly tagged to Bolt Biotherapeutics BOLT.O , an unrelated entity, and has been withdrawn. There will be no substitute. STORY_NUMBER:nT
01-22 23:28
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
Bolt Biotherapeutics shares are trading higher after the company reported better-than-expected Q3 financial results.
Bolt Biotherapeutics shares are trading higher after the company reported bette...
2025-11-13 22:18
Bolt Metals Corrects Private Placement Amount in Recent Announcement
An announcement from Bolt Metals ( ($TSE:BOLT) ) is now available. Bolt Metals ...
2025-10-24 01:39
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
2025-10-21 18:13
HC Wainwright & Co. Assumes Bolt Biotherapeutics at Buy, Announces Price Target of $7
HC Wainwright & Co. analyst Robert Burns assumes Bolt Biotherapeutics (NASDAQ:BOLT) with a Buy rating and announces Price Target of $7.
2025-10-20 18:44
